Analysis of Tregs revealed that rBCG reduced the frequency of CD25+ FoxP3+ cells both in the spleen (Figure 9D) and in the tumor (Figure 9E), mitigating immunosuppressive mechanisms. The gene discussed is FOXP3; the disease is neoplasm.